GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a remarkable innovation in how we approach diabetes mellitus . These injectable therapies work by imitating the body’s own GLP-1 substance https://bouchesocial.com/story24057193/glp-1-a-revolutionary-approach-in-diabetes-management